Gernandt & Danielsson advises Volati in the acquisition of NaturaMed Pharma
NaturaMed Pharma is one of the leading suppliers in Scandinavia of supplements, medicinal products, and health- and sports products where sales are made directly to the consumer through mail order and subscription services in Norway, Finland and Sweden. During the past 12 months up until 31 March 2014, NaturaMed Pharma’s turnover was SEK 192 million and its operating income before depreciations was SEK 50 million.
Volati is an industrial investor that develops companies with focus on the long-term creation of value. At present Volati has a turnover exceeding SEK 1.7 billion.
Gernandt & Danielsson advises Volati with a team consisting of partner Mikael Borg, senior associates Sara Zachrisson (M&A) and Sofie Viktorsson (financing), and associates Gabriel Zsiga (M&A) and Helén Landenberg (financing).Print